Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma
2ClH/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15
including SETD7
InChiKey: HURFJQIYDCUMPC-UHFFFAOYSA-N
and increases the persistence of camptothecin-induced DNA single-strand breaks
RU-SKI 43 Hydrochloride Size:Solid 2 mg Phase II study of theRU SKI 43 is an inhibitor of Hat. It blocks palmitoylation of Shh without affecting palmitoylation of H Ras or Fyn, myristoylation of c Src, or acylation of Wnt3a. RU SKI 43 reduced pancreatic cancer cell proliferation and Gli 1 activation through Smoothened independent non canonical signaling. In addition, RU SKI 43 treatment inhibited two key proliferative pathways regulated by Akt and mTOR. Product information CAS Number: 1782573 67 4 Molecular
US$ 142.00
US$ 252.50
US$ 309.00